nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—Gastrointestinal symptom NOS—Octreotide—thymus cancer	0.0477	0.0783	CcSEcCtD
Nimodipine—Haematoma—Octreotide—thymus cancer	0.0446	0.0733	CcSEcCtD
Nimodipine—Acne—Octreotide—thymus cancer	0.0333	0.0547	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.028	0.046	CcSEcCtD
Nimodipine—Wheezing—Octreotide—thymus cancer	0.0272	0.0447	CcSEcCtD
Nimodipine—Phlebitis—Octreotide—thymus cancer	0.0236	0.0388	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0234	0.0384	CcSEcCtD
Nimodipine—Cardiac failure congestive—Octreotide—thymus cancer	0.0224	0.0369	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.0203	0.0334	CcSEcCtD
Nimodipine—CACNB4—thyroid gland—thymus cancer	0.0185	0.0507	CbGeAlD
Nimodipine—Cramp muscle—Octreotide—thymus cancer	0.0183	0.0301	CcSEcCtD
Nimodipine—Sweating increased—Octreotide—thymus cancer	0.0171	0.0281	CcSEcCtD
Nimodipine—CACNB4—lung—thymus cancer	0.0168	0.0461	CbGeAlD
Nimodipine—CACNB3—pituitary gland—thymus cancer	0.0165	0.0451	CbGeAlD
Nimodipine—CACNA1S—thyroid gland—thymus cancer	0.0159	0.0434	CbGeAlD
Nimodipine—Depression—Octreotide—thymus cancer	0.0156	0.0257	CcSEcCtD
Nimodipine—Jaundice—Octreotide—thymus cancer	0.0153	0.0251	CcSEcCtD
Nimodipine—Hepatobiliary disease—Octreotide—thymus cancer	0.0148	0.0244	CcSEcCtD
Nimodipine—CACNB1—thyroid gland—thymus cancer	0.0148	0.0405	CbGeAlD
Nimodipine—Bradycardia—Octreotide—thymus cancer	0.0143	0.0235	CcSEcCtD
Nimodipine—CACNB3—thyroid gland—thymus cancer	0.0142	0.0389	CbGeAlD
Nimodipine—Hepatitis—Octreotide—thymus cancer	0.0141	0.0231	CcSEcCtD
Nimodipine—Cardiac disorder—Octreotide—thymus cancer	0.0131	0.0215	CcSEcCtD
Nimodipine—Flushing—Octreotide—thymus cancer	0.0131	0.0215	CcSEcCtD
Nimodipine—CACNB3—lung—thymus cancer	0.0129	0.0353	CbGeAlD
Nimodipine—Immune system disorder—Octreotide—thymus cancer	0.0127	0.0209	CcSEcCtD
Nimodipine—AHR—cardiac atrium—thymus cancer	0.0125	0.0342	CbGeAlD
Nimodipine—AHR—pituitary gland—thymus cancer	0.0122	0.0334	CbGeAlD
Nimodipine—Muscle spasms—Octreotide—thymus cancer	0.0118	0.0194	CcSEcCtD
Nimodipine—CACNB2—cardiac atrium—thymus cancer	0.0113	0.031	CbGeAlD
Nimodipine—Anaemia—Octreotide—thymus cancer	0.0113	0.0186	CcSEcCtD
Nimodipine—CACNB2—pituitary gland—thymus cancer	0.0111	0.0303	CbGeAlD
Nimodipine—NR3C2—hematopoietic system—thymus cancer	0.011	0.03	CbGeAlD
Nimodipine—Palpitations—Octreotide—thymus cancer	0.0108	0.0178	CcSEcCtD
Nimodipine—Hypertension—Octreotide—thymus cancer	0.0106	0.0174	CcSEcCtD
Nimodipine—AHR—bone marrow—thymus cancer	0.0105	0.0289	CbGeAlD
Nimodipine—AHR—thyroid gland—thymus cancer	0.0105	0.0288	CbGeAlD
Nimodipine—Myalgia—Octreotide—thymus cancer	0.0104	0.0171	CcSEcCtD
Nimodipine—Oedema—Octreotide—thymus cancer	0.01	0.0164	CcSEcCtD
Nimodipine—CACNA1D—cardiac atrium—thymus cancer	0.0099	0.0271	CbGeAlD
Nimodipine—Nervous system disorder—Octreotide—thymus cancer	0.00981	0.0161	CcSEcCtD
Nimodipine—Thrombocytopenia—Octreotide—thymus cancer	0.00979	0.0161	CcSEcCtD
Nimodipine—Tachycardia—Octreotide—thymus cancer	0.00976	0.016	CcSEcCtD
Nimodipine—CACNA1D—pituitary gland—thymus cancer	0.00968	0.0265	CbGeAlD
Nimodipine—Hyperhidrosis—Octreotide—thymus cancer	0.00967	0.0159	CcSEcCtD
Nimodipine—AHR—lung—thymus cancer	0.00956	0.0261	CbGeAlD
Nimodipine—CACNB2—thyroid gland—thymus cancer	0.00954	0.0261	CbGeAlD
Nimodipine—CACNB1—lymph node—thymus cancer	0.0092	0.0252	CbGeAlD
Nimodipine—CACNA1C—cardiac atrium—thymus cancer	0.00914	0.025	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00911	0.015	CcSEcCtD
Nimodipine—CACNA1C—pituitary gland—thymus cancer	0.00893	0.0244	CbGeAlD
Nimodipine—Dyspnoea—Octreotide—thymus cancer	0.00891	0.0146	CcSEcCtD
Nimodipine—CACNB3—lymph node—thymus cancer	0.00882	0.0241	CbGeAlD
Nimodipine—CACNB2—lung—thymus cancer	0.00867	0.0237	CbGeAlD
Nimodipine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00863	0.0142	CcSEcCtD
Nimodipine—CACNA1D—thyroid gland—thymus cancer	0.00834	0.0228	CbGeAlD
Nimodipine—NR3C2—cardiac atrium—thymus cancer	0.00832	0.0228	CbGeAlD
Nimodipine—NR3C2—pituitary gland—thymus cancer	0.00813	0.0222	CbGeAlD
Nimodipine—CACNA1D—lung—thymus cancer	0.00758	0.0207	CbGeAlD
Nimodipine—Hypersensitivity—Octreotide—thymus cancer	0.00737	0.0121	CcSEcCtD
Nimodipine—Pruritus—Octreotide—thymus cancer	0.00707	0.0116	CcSEcCtD
Nimodipine—NR3C2—thyroid gland—thymus cancer	0.00701	0.0192	CbGeAlD
Nimodipine—CACNA1C—lung—thymus cancer	0.00699	0.0191	CbGeAlD
Nimodipine—Diarrhoea—Octreotide—thymus cancer	0.00684	0.0112	CcSEcCtD
Nimodipine—Dizziness—Octreotide—thymus cancer	0.00661	0.0109	CcSEcCtD
Nimodipine—AHR—lymph node—thymus cancer	0.00654	0.0179	CbGeAlD
Nimodipine—NR3C2—lung—thymus cancer	0.00637	0.0174	CbGeAlD
Nimodipine—Vomiting—Octreotide—thymus cancer	0.00636	0.0104	CcSEcCtD
Nimodipine—Rash—Octreotide—thymus cancer	0.0063	0.0104	CcSEcCtD
Nimodipine—Dermatitis—Octreotide—thymus cancer	0.0063	0.0103	CcSEcCtD
Nimodipine—Headache—Octreotide—thymus cancer	0.00626	0.0103	CcSEcCtD
Nimodipine—Nausea—Octreotide—thymus cancer	0.00594	0.00976	CcSEcCtD
Nimodipine—CACNB2—lymph node—thymus cancer	0.00593	0.0162	CbGeAlD
Nimodipine—CYP3A5—hematopoietic system—thymus cancer	0.00592	0.0162	CbGeAlD
Nimodipine—CACNA1D—lymph node—thymus cancer	0.00518	0.0142	CbGeAlD
Nimodipine—CACNA1C—lymph node—thymus cancer	0.00478	0.0131	CbGeAlD
Nimodipine—CYP3A4—hematopoietic system—thymus cancer	0.00445	0.0122	CbGeAlD
Nimodipine—NR3C2—lymph node—thymus cancer	0.00435	0.0119	CbGeAlD
Nimodipine—CYP3A5—lung—thymus cancer	0.00344	0.00941	CbGeAlD
Nimodipine—CACNB4—Neuronal System—KCNA4—thymus cancer	0.0024	0.0934	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—KCNA4—thymus cancer	0.00192	0.0746	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—DPYSL5—thymus cancer	0.0019	0.0738	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—KCNA4—thymus cancer	0.00187	0.0726	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—DPYSL5—thymus cancer	0.00152	0.059	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—DPYSL5—thymus cancer	0.00148	0.0574	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—DPYSL5—thymus cancer	0.00136	0.0527	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—KCNA4—thymus cancer	0.00117	0.0456	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—DPYSL5—thymus cancer	0.00108	0.0421	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—DPYSL5—thymus cancer	0.00108	0.0421	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—DPYSL5—thymus cancer	0.00106	0.041	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.000955	0.0371	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—DPYSL5—thymus cancer	0.000928	0.0361	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—DPYSL5—thymus cancer	0.000879	0.0341	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—DPYSL5—thymus cancer	0.000773	0.03	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—DPYSL5—thymus cancer	0.000773	0.03	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—DPYSL5—thymus cancer	0.000663	0.0257	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—DPYSL5—thymus cancer	0.000627	0.0244	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—TP53—thymus cancer	0.000574	0.0223	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—DPYSL5—thymus cancer	0.000551	0.0214	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MAML2—thymus cancer	0.000341	0.0133	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000237	0.00921	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—thymus cancer	0.00023	0.00895	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.0002	0.00777	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—TP53—thymus cancer	0.000189	0.00732	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—thymus cancer	0.000187	0.00727	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—thymus cancer	0.000164	0.00639	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MAML2—thymus cancer	0.000164	0.00638	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—thymus cancer	7.88e-05	0.00306	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—thymus cancer	6.3e-05	0.00245	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—thymus cancer	6.13e-05	0.00238	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—thymus cancer	4.49e-05	0.00174	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—thymus cancer	3.85e-05	0.0015	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—thymus cancer	3.65e-05	0.00142	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—thymus cancer	3.2e-05	0.00124	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—thymus cancer	2.89e-05	0.00112	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—thymus cancer	2.51e-05	0.000974	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—thymus cancer	1.53e-05	0.000595	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—thymus cancer	1.45e-05	0.000563	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—thymus cancer	1.27e-05	0.000495	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—thymus cancer	5.64e-06	0.000219	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—thymus cancer	2.62e-06	0.000102	CbGpPWpGaD
